Big Gain For Intercept Pharmaceuticals, Inc.
Tue, Sep 26, 2023 at 07:59 PM
Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ) soared at $18.71, representing a gain of 79.2%. On Tue, Sep 26, 2023, ICPT:NASDAQ touched a New 2-Week High of $18.71. The stock appeared on our News Catalysts scanner on Tue, Sep 26, 2023 at 10:32 AM in the 'ACQUISITION' category. From Tue, Sep 12, 2023, the stock recorded 10.00% Up Days and 27.27% Green Days
About Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ)
Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.
Top 10 Gainers:
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 504.97%
- Femasys Inc. (FEMY:NASDAQ), 346.32%
- Signature Bank (SBNY:NASDAQ), 105.88%
- Immunovant, Inc. (IMVT:NASDAQ), 97.04%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ), 79.21%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 64.71%
- DMK Pharmaceuticals Corp Com Par $0.001 (DMK:NASDAQ), 59.25%
- Minerva Surgical Inc. (UTRS:NASDAQ), 55.22%
- Acasti Pharma Inc. (ACST:NASDAQ), 37.71%